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Acute and intentional poisoning is one of the most common reasons 
why pregnant and non-pregnant patients present to the emergency 
department of a health service. Young patients are most commonly 
affected, with a high mortality rate. In most instances, the ingested 
agent(s) is unknown. Only the victim knows what happened, and at 
presentation they might be unable to communicate the information. 
The first responder is the second-best person to identify the poison, 
which rarely occurs. Agitation that progresses to central nervous 
system depression and subsequent coma is common in the majority 
of toxin cases.
The files of women classified as coincidental deaths by the National 
Committee on Confidential Enquiries into Maternal Deaths were 
examined to establish if those who might have died from poisoning 
could be identified. Some examples are presented. Organophosphate 
ingestion appeared to be a fairly common cause of poisoning that 
resulted in maternal deaths. Signs and symptoms of such poisoning 
are discussed.
Case 1
A teenage primigravida presented to her local clinic during the 
first trimester of pregnancy, requesting termination of pregnancy 
(TOP). No management plan was prepared regarding her request, 
despite repeated visits. She was also HIV-positive, her CD4 count 
was unknown and she started antiretroviral treatment. Three months 
later the acutely ill patient presented at a tertiary hospital and 
was admitted to the antenatal ward. She was administered fluids 
and antibiotics, but she progressively deteriorated. She was then 
transferred to a high-dependency ward and died within an hour of 
admission from multi-organ (renal, respiratory, haematological and 
metabolic) failure secondary to suspected poisoning.
Lessons learnt
• Take requests for TOP seriously, construct clear management plans 
and document them. Involve a social worker.
• Do not underestimate the clinical condition of a patient in respi-
ratory distress.
Case 2
A teenage primigravida who had not attended antenatal care was 
admitted to a district hospital 6 hours after taking an overdose of a 
known substance. She was clinically in shock and was admitted for 
3 days; her condition became progressively worse. She died on the 
third day while waiting for a transfer to a higher level of care. During 
the time at the district hospital, she mainly received nursing care and 
occasional telephonic advice from a doctor.
Lessons learnt
• Do not delay referral of critically ill patients.
• Request doctors to personally review ill patients.
Case 3
A young woman in her early twenties, who previously delivered a baby 
by caesarean section, was now in her third trimester and received no 
antenatal care. She was found dead at home after carbamate ingestion.
Lesson learnt
• Emphasise the importance of (long-acting) contraception post partum 
and during every contact with the health system.
Case 4
A 20-year-old pregnant woman who had not attended antenatal care 
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Organophosphate poisoning seems to be a fairly common cause of mortality in young and teenage mothers. The attending healthcare 
personnel, especially nursing staff and doctors, should always have a high index of suspicion when attending to teenagers who have never 
initiated antenatal care or those who request termination of pregnancy (TOP), because often – if these patients are not assisted – they choose 
unsafe, unauthorised alternatives, which could have dire consequences. A management plan should always include preventive measures, 
attempts to diagnose, and prompt, directed immediate and maintenance therapies. Preventive measures must include clear decisive plans 
on how to manage women who request TOP and advocacy for use of long-acting reversible contraception, including the intra-uterine 
device, for all young women who are at any time in contact with the health system. Early and correct diagnosis is mainly guided by the 
history, including a collateral history if the woman is unresponsive. Attending health personnel are usually able to establish substance 
ingestion accompanied by a varying degree of symptoms – from nausea, vomiting, hypersecretions, headache, severe confusion, pinpoint 
pupils, bradycardia, tachypnoea/bradypnoea, hypertension/hypotension to convulsions, coma and eventually death. The basic concepts of 
multidisciplinary team resuscitation, including the Airway, Breathing, Circulation, Disability, Exposure (ABCDE) approach, should always 
be followed to stabilise the patient, while trying to elicit the cause and thus assist with further management.
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presented at a hospital with a history of vomiting, diarrhoea and 
collapse. On arrival, she had pinpoint pupils and she was unresponsive, 
with copious secretions and bilateral chest crepitations. The patient 
was initially normotensive, but suddenly became hypotensive and 
bradycardic. She was intubated and transferred to a higher level of care, 
where she died shortly after arrival from suspected organophosphate 
poisoning.
Lessons learnt
• Stabilise the patient before referral.
• Know the initial steps of stabilisation for organophosphate 
poisoning.
Discussion 
• Organophosphates were first synthesised during the 19th century by 
French chemist Louis Lassaigne. During World War II, the German 
chemist, Gerhard Schrader, synthesised many commercial insecticides 
and chemical warfare agents, such as tabun and sarin. Shortly after the 
war, organophosphates were used widely as pesticides.[1] 
• Organophosphates are easily accessible and self-poisoning is an 
important clinical problem in rural regions of the developing 
world, with >200 000 deaths yearly.
• They can be absorbed through the skin, lungs and gastrointestinal 
tract.[2,3]
Pathogenesis and clinical presentation 
• Organophosphates act mainly by inhibiting acetylcholinesterase 
action, thereby leading to accumulation of acetylcholine and 
subsequent overstimulation of muscarinic and nicotinic receptors.
• The degree of neurotoxicity and severity can be determined by 
direct measurement of the true (red blood cell) cholinesterase 
activity and can be classified as mild (>40% activity), moderate 
(20 - 40% activity) and severe (<20% activity).
• Patients may present with varying degrees of clinical symptomatology, 
ranging from nausea, vomiting, hypersecretions (bronchorrhoea, 
urination, diarrhoea), headache, severe confusion, pinpoint pupils, 
bradycardia, tachypnoea/bradypnoea, and hypertension/hypotension 
to convulsions, coma and eventually death.[4]
Natural progression after exposure
Clinical phases of organophosphate poisoning include the following:
• Acute cholinergic crisis – within 24 hours after the initial 
presentation, and described in patient 4. 
• Intermediate syndrome – typically occurs within 24 - 96 hours 
and is dependent on the reversibility of enzyme blockade. This 
can also affect the consciousness of patients without cholinergic 
signs or those who were apparently successfully treated for 
acute cholinergic crisis. It involves paralysis of the muscles of 
respiration, proximal limb muscles, neck flexors and muscles 
innervated by motor cranial nerves. Appropriate therapy that 
commonly includes artificial respiration yields complete recovery 
5 - 18 days later.[5] 
• Delayed neuropathy – involves both the peripheral and 
central nervous systems. It is characterised by motor and sensory 
Table 1. Acute/immediate management of organophosphate poisoning
Management Intervention Comments
Airway Stabilisation 
Intubate if threatened airway or unconscious
Be ready for difficult airway
Protects against aspiration
Drug interactions may occur with certain toxins; 
therefore, use of some agents, e.g. suxamethonium, 
is contraindicated because of delayed action from 
unavailable cholinesterase enzyme for its metabolism
Breathing High-flow oxygen, invasive or non-invasive ventilatory 
support
Respiratory parameters, e.g. minute ventilation; 
oxygenation should guide the use of these interventions
Circulation Rapid infusion with isotonic solutions, including 
vasopressors/inotropes, should be timeously 
considered
Define targets, e.g. urine output (≥0.5 mL/kg/h), lactate 
clearance, mean arterial pressure 
Appropriate laboratory testing, including 
cholinesterase levels, glucose levels, blood count, urea 
and electrolyte levels, acetaminophen and salicylate 
levels, and other specific drug and enzymes levels
Comprehensive urine drug testing
Guides multiple-agent ingestion, degree of organ 
involvement and directed treatment modalities
Disability and neurological 
stabilisation
Assessment by AVPU (Alert, response to Voice, 
response to Pain and Unconscious) should be 
performed immediately and patients appropriately 
managed
Rapid deterioration is highly possible
Seizures are best aborted with benzodiazepines
Administer propofol if benzodiapines are ineffective
There might be other causes of seizures, and specific 
antidotes may be necessary, e.g. pyridoxime for 
isoniazid poisoning
Exposure and elimination Remove soiled clothing and containers and wash with 
soap containing 30% ethanol
Reduces risks to healthcare workers and continued 
patient exposure 
Other Identify any injuries
Gastric lavage Only after stabilisation and treatment with oxygen, 
atropine and oximes may be administered
Activated charcoal No mortality benefit due to rapid absorption of 
pesticide into blood
Haemodialysis No clear role
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neuropathies. Rehabilitation programmes are usually necessary 
for full recovery.
Management
In severe poisoning, organised targeted resuscitation is mandatory 
and can be lifesaving:
• The basic concepts of multidisciplinary team resuscitation 
(Airway, Breathing, Circulation, Disability, Exposure (ABCDE)) 
should always be followed (Table 1). The goals are to stabilise the 
patient, while trying to elicit the cause, and thus assist with further 
management.
• There are common syndromes associated with different poison-
ous agent(s), such as sympathomimetics, opioids, sedatives, 
cholinergics, anticholinergics, hallucinogens and serotonins. 
• Patients might gain access to any of these abovementioned agents. 
Initially it may not be possible to exclude poisoning with multiple 
agents.
• Immediate intravenous access and cardiac and respiratory 
monitoring should be implemented.
• Clinical signs and symptoms guide management of these patients in 
most instances, as testing for poisons is not always readily available.
• Treatment includes atropinisation (initiated as a rapid bolus of 2.0 
- 4.0 mg atropine followed by 0.5 - 2.0 mg every 10 - 15 minutes, 
or by infusion until atropinisation is achieved, and a subsequent 
maintenance dose given thereafter; this can be administered for 
several days to achieve full recovery). 
• It is important to define targets, such as improved secretions, pupil 
size and pulse response, to guide atropinisation and detect atropine 
toxicity.
• In situations where there is doubt about the need for atropine, 
a test can be performed, whereby 1.0 mg atropine is given. The 
response (tachycardia with skin flushing) will indicate whether 
further administration of the agent is indicated.
• The use of pralidoxime to reactivate cholinesterase is controversial 
and influenced by many factors, such as rate of inhibition and 
cholinesterase ageing. However, the World Health Organization 
recommends its use in patients requiring atropine and those with 
evidence of cholinergic toxicity, neuromuscular dysfunction and 
exposure to agents with delayed neurotoxicity. 
• Symptomatic systemic support (Table 1) is mandatory.
Very importantly, prolonged resuscitation efforts are usually not 
futile in these patients and previously healthy patients have a better 
prognosis.[6-9]
Subsequent management
• Multidisciplinary (should include a toxicologist, poison centre 
personnel, physician, intensivist, obstetrician and gynaecologist, 
psychologist, social worker) teamwork is involved regarding defini tive 
diagnosis, progressive, co-ordinated weaning of acute treatment, 
subsequent de-escalation of care and post-intensive care unit 
management.
• There should be monitoring and management of complications. 
• Attention should be given to the patient’s psychosocial stressors to 
prevent repeated poisoing attempts.
Organophosphates in pregnancy
• Not well studied or reported.
• Mainly retrospective cases – the majority of patients received 
atropine and ventilator care.
• There were no immediate congenital abnormalities or neurological 
deficits in babies.
• The majority of maternal deaths occurred during the acute 
cholinergic crisis and intermediate syndrome phases of organo-
phosphate poisoning.[10]
Summary
• Unplanned and unwanted pregnancies in young women are a reality. 
• Young women with organophosphate poisoning have usually not 
attended antenatal care and/or have a history of a previous request 
for TOP. 
• Organophosphates are easily accessible and a high index of suspi-
cion should be maintained in these young women.
• The initial diagnosis may not be obvious; however, clinical 
signs of mental alteration (confusion, headaches, restlessness and 
possibly collapse), pinpoint pupils and hypersecretions (diarrhoea, 
urination, bronchorrhoea) with shortness of breath or respiratory 
distress should alert the clinician regarding the diagnosis of 
organophosphate poisoning.
• The initial assessment, ABCDE and management with appropriate 
system support, including rapid atropinisation and early mechani-
cal ventilation, are mandatory.
• Ingestion of more than one toxin may be a possibility.
• Be prepared for delayed presentation after recovery from the acute 
cholinergic crisis.
We should look for the ‘she’s’: ‘She says she’s fine, but she’s going 
insane. She says she feels good, but she is in a lot of pain. She says it 
is nothing, but it is really a lot. She says she is okay, but really she’s 
not.’ Many lives could be saved if detected early by primary healthcare 
personnel, mainly doctors! 
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